Spider Telangiectasias Pediatric Research and Clinical Trials

At Boston Children's Hospital, we’re known for our science-driven approach. We’re home to the world's most extensive pediatric hospital research enterprise; and we partner with elite health care and biotech organizations around the globe.

Our Vascular Anomalies Center (VAC) conducts research that may lead to the development of new, more effective therapies for spider telangiectasias and perhaps ultimately result in ways to prevent these anomalies. The VAC has generated an extensive case database on vascular anomalies. As our database grows, it will help shine more light on spider telangiectasias and other vascular anomalies.

Spider telangiectasias: Reviewed by Marilyn Liang, MD
© Boston Children's Hospital, 2015